The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Testosterone Replacement Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
The global Testosterone Replacement Therapy market size is expected to reach US$ 1134.6 million by 2029, growing at a CAGR of -4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Testosterone Replacement Therapy in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Testosterone Replacement Therapy market. Gels, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injections segment is estimated at % CAGR for the next seven-year period.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Testosterone Replacement Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Testosterone Replacement Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Testosterone Replacement Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Testosterone Replacement Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Testosterone Replacement Therapy covered in this report include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva and Mylan, etc.
The global Testosterone Replacement Therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Global Testosterone Replacement Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Testosterone Replacement Therapy market, Segment by Type:
Gels
Injections
Patches
Other
Global Testosterone Replacement Therapy market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Testosterone Replacement Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Testosterone Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
The global Testosterone Replacement Therapy market size is expected to reach US$ 1134.6 million by 2029, growing at a CAGR of -4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Testosterone Replacement Therapy in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Testosterone Replacement Therapy market. Gels, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injections segment is estimated at % CAGR for the next seven-year period.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Testosterone Replacement Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Testosterone Replacement Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Testosterone Replacement Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Testosterone Replacement Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Testosterone Replacement Therapy covered in this report include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva and Mylan, etc.
The global Testosterone Replacement Therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Global Testosterone Replacement Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Testosterone Replacement Therapy market, Segment by Type:
Gels
Injections
Patches
Other
Global Testosterone Replacement Therapy market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Testosterone Replacement Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Testosterone Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Testosterone Replacement Therapy Market Overview
1.1 Testosterone Replacement Therapy Product Overview
1.2 Testosterone Replacement Therapy Market Segment by Type
1.2.1 Gels
1.2.2 Injections
1.2.3 Patches
1.2.4 Other
1.3 Global Testosterone Replacement Therapy Market Size by Type
1.3.1 Global Testosterone Replacement Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Testosterone Replacement Therapy Historic Market Size Review by Type (2018-2023)
1.3.3 Global Testosterone Replacement Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Testosterone Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.2 Europe Testosterone Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Testosterone Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Testosterone Replacement Therapy Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Testosterone Replacement Therapy Sales Breakdown by Type (2018-2023)
2 Global Testosterone Replacement Therapy Market Competition by Company
2.1 Global Top Players by Testosterone Replacement Therapy Sales (2018-2023)
2.2 Global Top Players by Testosterone Replacement Therapy Revenue (2018-2023)
2.3 Global Top Players by Testosterone Replacement Therapy Price (2018-2023)
2.4 Global Top Manufacturers Testosterone Replacement Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Testosterone Replacement Therapy Market Competitive Situation and Trends
2.5.1 Testosterone Replacement Therapy Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Testosterone Replacement Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Testosterone Replacement Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Testosterone Replacement Therapy Market
2.8 Key Manufacturers Testosterone Replacement Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Testosterone Replacement Therapy Status and Outlook by Region
3.1 Global Testosterone Replacement Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Testosterone Replacement Therapy Historic Market Size by Region
3.2.1 Global Testosterone Replacement Therapy Sales in Volume by Region (2018-2023)
3.2.2 Global Testosterone Replacement Therapy Sales in Value by Region (2018-2023)
3.2.3 Global Testosterone Replacement Therapy Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Testosterone Replacement Therapy Forecasted Market Size by Region
3.3.1 Global Testosterone Replacement Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Testosterone Replacement Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Testosterone Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Testosterone Replacement Therapy by Application
4.1 Testosterone Replacement Therapy Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Testosterone Replacement Therapy Market Size by Application
4.2.1 Global Testosterone Replacement Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Testosterone Replacement Therapy Historic Market Size Review by Application (2018-2023)
4.2.3 Global Testosterone Replacement Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Testosterone Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.2 Europe Testosterone Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Testosterone Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Testosterone Replacement Therapy Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Testosterone Replacement Therapy Sales Breakdown by Application (2018-2023)
5 North America Testosterone Replacement Therapy by Country
5.1 North America Testosterone Replacement Therapy Historic Market Size by Country
5.1.1 North America Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Testosterone Replacement Therapy Sales in Volume by Country (2018-2023)
5.1.3 North America Testosterone Replacement Therapy Sales in Value by Country (2018-2023)
5.2 North America Testosterone Replacement Therapy Forecasted Market Size by Country
5.2.1 North America Testosterone Replacement Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Testosterone Replacement Therapy Sales in Value by Country (2024-2029)
6 Europe Testosterone Replacement Therapy by Country
6.1 Europe Testosterone Replacement Therapy Historic Market Size by Country
6.1.1 Europe Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Testosterone Replacement Therapy Sales in Volume by Country (2018-2023)
6.1.3 Europe Testosterone Replacement Therapy Sales in Value by Country (2018-2023)
6.2 Europe Testosterone Replacement Therapy Forecasted Market Size by Country
6.2.1 Europe Testosterone Replacement Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Testosterone Replacement Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Testosterone Replacement Therapy by Region
7.1 Asia-Pacific Testosterone Replacement Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Testosterone Replacement Therapy Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Testosterone Replacement Therapy Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Testosterone Replacement Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Testosterone Replacement Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Testosterone Replacement Therapy Sales in Value by Region (2024-2029)
8 Latin America Testosterone Replacement Therapy by Country
8.1 Latin America Testosterone Replacement Therapy Historic Market Size by Country
8.1.1 Latin America Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Testosterone Replacement Therapy Sales in Volume by Country (2018-2023)
8.1.3 Latin America Testosterone Replacement Therapy Sales in Value by Country (2018-2023)
8.2 Latin America Testosterone Replacement Therapy Forecasted Market Size by Country
8.2.1 Latin America Testosterone Replacement Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Testosterone Replacement Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Testosterone Replacement Therapy by Country
9.1 Middle East and Africa Testosterone Replacement Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Testosterone Replacement Therapy Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Testosterone Replacement Therapy Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Testosterone Replacement Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Testosterone Replacement Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Testosterone Replacement Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Testosterone Replacement Therapy Products Offered
10.1.5 AbbVie Recent Development
10.2 Endo International
10.2.1 Endo International Company Information
10.2.2 Endo International Introduction and Business Overview
10.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Endo International Testosterone Replacement Therapy Products Offered
10.2.5 Endo International Recent Development
10.3 Eli lilly
10.3.1 Eli lilly Company Information
10.3.2 Eli lilly Introduction and Business Overview
10.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli lilly Testosterone Replacement Therapy Products Offered
10.3.5 Eli lilly Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Testosterone Replacement Therapy Products Offered
10.4.5 Pfizer Recent Development
10.5 Actavis (Allergan)
10.5.1 Actavis (Allergan) Company Information
10.5.2 Actavis (Allergan) Introduction and Business Overview
10.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products Offered
10.5.5 Actavis (Allergan) Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Testosterone Replacement Therapy Products Offered
10.6.5 Bayer Recent Development
10.7 Novartis
10.7.1 Novartis Company Information
10.7.2 Novartis Introduction and Business Overview
10.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis Testosterone Replacement Therapy Products Offered
10.7.5 Novartis Recent Development
10.8 Teva
10.8.1 Teva Company Information
10.8.2 Teva Introduction and Business Overview
10.8.3 Teva Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Testosterone Replacement Therapy Products Offered
10.8.5 Teva Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Testosterone Replacement Therapy Products Offered
10.9.5 Mylan Recent Development
10.10 Upsher-Smith
10.10.1 Upsher-Smith Company Information
10.10.2 Upsher-Smith Introduction and Business Overview
10.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Upsher-Smith Testosterone Replacement Therapy Products Offered
10.10.5 Upsher-Smith Recent Development
10.11 Ferring Pharmaceuticals
10.11.1 Ferring Pharmaceuticals Company Information
10.11.2 Ferring Pharmaceuticals Introduction and Business Overview
10.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Products Offered
10.11.5 Ferring Pharmaceuticals Recent Development
10.12 Kyowa Kirin
10.12.1 Kyowa Kirin Company Information
10.12.2 Kyowa Kirin Introduction and Business Overview
10.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kyowa Kirin Testosterone Replacement Therapy Products Offered
10.12.5 Kyowa Kirin Recent Development
10.13 Acerus Pharmaceuticals
10.13.1 Acerus Pharmaceuticals Company Information
10.13.2 Acerus Pharmaceuticals Introduction and Business Overview
10.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Products Offered
10.13.5 Acerus Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Testosterone Replacement Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Testosterone Replacement Therapy Industrial Chain Analysis
11.4 Testosterone Replacement Therapy Market Dynamics
11.4.1 Testosterone Replacement Therapy Industry Trends
11.4.2 Testosterone Replacement Therapy Market Drivers
11.4.3 Testosterone Replacement Therapy Market Challenges
11.4.4 Testosterone Replacement Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Testosterone Replacement Therapy Distributors
12.3 Testosterone Replacement Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
